OAB-048: An interim analysis of a phase I/II single arm study of belantamab mafodotin, carfilzomib and dexamethasone in patients with relapsed multiple myeloma: AMaRC 19-02 BelaCarD study
Titel:
OAB-048: An interim analysis of a phase I/II single arm study of belantamab mafodotin, carfilzomib and dexamethasone in patients with relapsed multiple myeloma: AMaRC 19-02 BelaCarD study
Auteur:
Lasica, Masa Spencer, Andrew Campbell, Philip Wallington-Gates, Craig Doo, Nicole Wong Janowski, Wojciech McCaughan, Georgia Puliyayil, Anish Yuen, Flora Le, Khoa Reynolds, John Quach, Hang